KDDI Corporation

9433.T Q1 2027

Reported: 2026-08-10

The stock edged up modestly by 2.8%, reflecting investor caution despite steady top-line growth and margin stability. Market reaction suggests relief at consistent execution but no material beat or revision to guidance.

Key takeaways

Operating revenue rose 5.1% year-on-year in Q1 with 23.2% progress toward the full year forecast of JPY 1,210 billion.
Adjusted operating income increased 21.1% year-on-year, with a progress rate of 26%, supported primarily by mobile communications revenue.
Mobile KPIs improved with active smartphones up 390K to 33.3 million and churn declining to 1.17%; mobile ARPU grew 3.8% to JPY 4,400.
Growth segments showed mixed performance: Personal Growth operating income up 9.3%, Business Growth up 21.6%, while Financial Business income declined JPY 3.7 billion due to anticipated mark-to-market losses.
AI-related revenue expansion remains a key focus with cloud infrastructure revenue up over 30% and EBITDA margin exceeding 40%, signaling ongoing investment in future growth areas.

View recap

Amplitude Inc. Class A Common Stock

AMPL Q2 2026

Reported: 2026-08-10

Amplitude’s stock rose 9.0% after Q2 2026 earnings, driven by solid top-line growth, strong ARR expansion including substantial inorganic contribution, and clear progress on its AI transformation strategy that resonated well with investors.

Key takeaways

Q2 revenue reached $101 million, growing 21% year over year, underscoring continued demand.
Total annual recurring revenue (ARR) was $410 million, up 22% year over year and up $36 million sequentially, with $17 million from the Statsig acquisition and $19 million organic growth.
Customers contributing more than $100K ARR increased 30% year over year to 824, led by both AI native companies and large enterprises.
Gross margins are expected to remain in the low 70% range due to higher inference costs from AI workloads, offset by planned reductions in operating expenses.
The company’s ongoing shift to an AI native model, including engineering efficiencies and new product offerings (Amplitude, Statsig, Wade), positions it to capture evolving market demand.

View recap

Ardelyx, Inc.

ARDX Q2 2026

Reported: 2026-08-10

Ardelyx shares fell 18.5% after the company cut guidance in response to growing payer hurdles that slowed new patient starts for IBSRELA, signaling investor concerns over demand deceleration despite revenue growth.

Key takeaways

Combined revenue from IBSRELA and XPHOZAH reached $118 million, up 31% year-over-year and the highest quarterly total in company history.
New patient starts for IBSRELA were materially impacted by increased payer restrictions, dampening growth momentum.
Refill rates and total prescriptions hit record highs, supported by the IBSRELA Pharmacy Network and expanded sales force initiatives.
The company highlighted ongoing efforts to mitigate payer barriers, including doubling the field reimbursement team and ramping up direct-to-consumer marketing.
Management reaffirmed long-term revenue potential but will no longer pursue further legal action regarding CMS reimbursement, removing a potential lever for future pricing flexibility.

View recap

Constellation Energy Corporation

CEG Q2 2026

Reported: 2026-08-10

Constellation’s shares rose modestly by 1.8% post-earnings, reflecting a solid quarter with an increased guidance update but arguably without the momentum to push the stock higher amid ongoing regulatory uncertainties and a multi-year timeline for key project restarts.

Key takeaways

Reported second quarter GAAP earnings of $1.42 per share and adjusted operating earnings of $2.55 per share.
Increased full-year adjusted operating earnings guidance by $0.50 to a range of $11.50 to $12.50 per share, with the midpoint now at the previous high end of guidance.
Signed approximately 920 megawatts of long-term nuclear contracts averaging 18.5 years with investment-grade customers, indicating progress in commercial execution.
Regulatory progress includes NRC approval of new fuel licensing for the Crane facility restart, expected in the second half of 2027, and FERC approval to transfer capacity injection rights from Eddystone to Crane.
Ongoing regulatory uncertainty and extended timelines for key asset restarts temper enthusiasm despite operational achievements and long-term contract wins.

View recap

COMPASS Pathways plc

CMPS Q2 2026

Reported: 2026-08-10

The stock surged 14.8% following the quarter, reflecting strong investor enthusiasm around COMPASS Pathways' highly statistically significant Phase III trial results for COMP360 and clear progress toward an NDA filing and launch readiness.

Key takeaways

Reported positive Phase III primary endpoint results demonstrating rapid and durable efficacy in treatment-resistant depression (TRD).
NDA rolling submission is underway with completion expected in Q4 2026 and potential for accelerated FDA approval.
Robust cash position of $433 million supports operations through launch and into 2028.
Commercial team fully built out with extensive launch experience; active preparations for sales force recruitment and market readiness.
Plans to leverage existing interventional psychiatry infrastructure (8,000+ sites), facilitating a smoother market entry.

View recap

Commerce.com, Inc.

CMRC Q2 2026

Reported: 2026-08-10

Shares fell 34.9% as investors reacted negatively to the cautious outlook and deliberate near-term revenue trade-offs embedded in the guidance, reflecting concerns over deceleration and margin pressure despite stable execution.

Key takeaways

Q2 revenue of $84.5 million came within guidance, while non-GAAP operating income of $8.1 million exceeded the high end, indicating operating leverage improvements.
Gross merchandise volume (GMV) grew 14% year-over-year to $8.8 billion, and net revenue retention improved sequentially for the third quarter to 95.8%.
Management emphasized structural shifts in the commerce landscape, including softer B2C replatforming and delayed monetization influenced by AI, signaling longer-term challenges.
The company is focusing investment on product intelligence and AI-driven commerce, intentionally reducing near-term revenue opportunities through narrowed ecosystems and partner rationalization.
Near-term outlook was cautious, reflecting deliberate decisions that trade off short-term growth for long-term positioning, which likely disappointed investors and pressured the stock.

View recap

Canadian Natural Resources Limited

CNQ.TO Q2 2026

Reported: 2026-08-10

The stock edged up modestly by 1.0% following Q2 results that delivered record production and solid financial performance but lacked a compelling catalyst to push shares higher. While operational execution and cash flow were strong, the market appears cautious, likely digesting unchanged capital spending and a modest production guidance raise.

Key takeaways

Total corporate production hit a record 1.68 million BOE/day in Q2, up 18% year-over-year, driven by oil sands mining and upgrading, conventional E&P, and in situ thermal operations.
Oil sands mining and upgrading netbacks reached a record ~$78/boe, benefiting from robust SCO pricing at a $8.37/boe premium to WTI and industry-low operating costs of $22.19/boe.
Adjusted net earnings were $4.6 billion ($2.20/share) with adjusted funds flow of $6.9 billion (~$3.30/share), both all-time company highs.
Capital program remains steady at approximately $6 billion, with a second increase this year in annual production guidance to 1.64-1.68 million BOE/day.
Returned $2.4 billion directly to shareholders in the quarter (dividends plus buybacks) and reduced net debt by $1.6 billion despite completing accretive acquisitions.

View recap

Digi International Inc.

DGII Q3 2026

Reported: 2026-08-10

Shares rallied 15.1% following a quarter marked by strong revenue growth and margin expansion that outpaced prior expectations, alongside an upward revision to full-year guidance.

Key takeaways

Q3 revenue reached $139 million, up 29% year-over-year, demonstrating solid top-line momentum.
Gross margins expanded to 64.8%, supporting a robust adjusted EBITDA margin of 29.1% and $40 million in adjusted EBITDA.
Cash flow from operations increased 38% year-over-year to $33 million, now exceeding the year-to-date adjusted EBITDA on an annualized basis.
Annual recurring revenue (ARR) hit a record of $191 million, with management projecting at least 27% ARR growth for the full year.
Q4 guidance was raised to $138–142 million in revenue and $40–41.5 million in adjusted EBITDA, lifting full-year revenue guidance to $529–533 million and adjusted EBITDA to $146–147.5 million, reflecting accelerating profitable growth.

View recap

Fluence Energy, Inc.

FLNC Q3 2026

Reported: 2026-08-10

Fluence Energy’s shares dropped 7.3% as investors reacted negatively to the lowered 2026 revenue and adjusted EBITDA guidance amid delays ramping up new manufacturing facilities, which weighed on near-term project deliveries and margins.

Key takeaways

Orders signed reached a record $1.44 billion in the quarter, nearly tripling last year’s pace and expanding backlog to $6.4 billion, up 14% sequentially.
Data center customer momentum accelerated with $850 million in initial orders and awards, growing the pipeline by over 35% quarter-over-quarter.
Revenue growth was hindered by delayed project deliveries tied to ramp-up issues at two new contracted manufacturing plants, notably the Houston facility.
The company lowered its 2026 guidance midpoint to $3 billion in revenue and negative $10 million adjusted EBITDA, signaling margin pressure and operational challenges.
Liquidity remained stable at approximately $860 million, supporting ongoing investment in capacity expansion despite near-term execution hurdles.

View recap

Gevo, Inc.

GEVO Q2 2026

Reported: 2026-08-10

Gevo shares rose modestly by 2.6% following Q2 results that show steady operational progress and an upgraded EBITDA outlook, but the market response suggests cautious optimism amid a significant non-cash impairment and ongoing capital expenditure risks.

Key takeaways

Revenue increased 7% sequentially, supported by stronger core low-carbon ethanol and renewable natural gas businesses.
Adjusted EBITDA guidance for full-year 2026 was raised to over $60 million, doubling prior estimates.
Successful Canada Clean Fuel Regulations (CFR) pathway approval expands access to a >1 billion gallon compliance market and unlocks retroactive carbon credit sales starting in Q3.
Debottlenecking at Gevo North Dakota plant remains on schedule to increase capacity by 10–15% this year and supports margin expansion in 2027.
A $176 million one-time non-cash impairment related to the exit from the ATJ-60 project in South Dakota indicates strategic shifts and non-core project write-downs.

View recap

Groupon, Inc.

GRPN Q2 2026

Reported: 2026-08-10

Groupon’s shares edged down 0.5% post-earnings, reflecting investor caution despite progress in AI-driven initiatives as North America Local revenue underperformed and revenue declined 1% year-over-year, missing expectations in the key segment.

Key takeaways

Q2 revenue and billings each declined 1% year-over-year, pressured by underperformance in North America Local.
Adjusted EBITDA finished at the high end of guidance, with free cash flow strong at +$15 million.
AI transformation efforts are underway; engineering productivity has more than doubled, and AI now handles thousands of hyperlocal marketing campaigns.
Organic search channel revenue returned to growth in Q2, accelerating to double-digit growth in July.
Q3 guidance expects 4%-6% billings growth, $128 million to $130 million revenue, adjusted EBITDA of $19 million to $21 million, and negative free cash flow.

View recap

IAMGOLD Corporation

IAG Q2 2026

Reported: 2026-08-10

IAMGOLD's shares rallied 14.3% post-earnings as robust cash flow generation and a clear capital return strategy, highlighted by aggressive share repurchases, bolstered investor confidence.

Key takeaways

Produced 188,100 ounces of gold in Q2, with year-to-date production of 371,700 ounces on track to meet full-year guidance of 720,000–820,000 ounces.
Mine site free cash flow reached nearly $900 million year-to-date, supporting $510 million in share repurchases since December.
Net operating cash flow for the quarter was $445.1 million, up sharply from $85.8 million in Q2 2025.
Cash costs including royalties were $1,289/oz in the quarter, tracking toward the upper half of guidance; higher royalties from realized gold prices (~$4,600/oz) and elevated oil prices added to costs.
Updated mine plans and growth initiatives at Cote, Essakane, Westwood, and Nelligan underpin long-term value creation, with Cote expansion studies and Essakane mine life extension expected later this year.

View recap

Infineon Technologies AG

IFNNY Q3 2026

Reported: 2026-08-10

Infineon’s stock declined 9% post-earnings, reflecting investor disappointment primarily driven by margin compression in the Green Industrial Power segment and cautious outlook signals, despite revenue growth and order momentum.

Key takeaways

Q3 revenue reached a new high at EUR 4.172 billion, up 9% sequentially and nearly 13% year-over-year.
Segment earnings margin improved to 19.1%, supported by volume and product mix effects, delivering EUR 797 million in earnings.
Automotive unit revenue grew 6% to EUR 1.932 billion with margin expansion to 18.4%, although margin headwinds from high-voltage power semiconductor realignment remain a drag.
Green Industrial Power revenue increased 11% to EUR 447 million, but segment earnings margin fell sharply to 9.8% from 11.7%, due to temporary operational and inventory factors.
Order backlog strengthened to nearly EUR 30 billion, signaling ongoing recovery momentum, but investors appear concerned over margin pressures and underlying profitability in key segments.

View recap

Lightbridge Corporation

LTBR Q2 2026

Reported: 2026-08-10

Shares rose 5.7% following a Q2 update that highlighted tangible progress on multiple fronts, notably the removal of irradiated fuel samples and strategic partnerships advancing licensing and commercial preparation.

Key takeaways

Successfully removed initial batch of fuel material samples from Idaho National Laboratory’s Advanced Test Reactor; post-irradiation examination to begin later this year, providing critical performance data under burn-up conditions.
Partnership established with Studsvik Scan Power to integrate Lightbridge fuel design into widely used core management software, facilitating adoption by utilities and supporting regulatory submissions.
Initiated feasibility and site selection studies for a commercial-scale fuel fabrication facility with Momentum Technology.
Continued organizational expansion with targeted hiring across core technical disciplines to build capacity through 2027-2028 while maintaining capital discipline.
Engagement at the federal level, represented at the White House for DOE’s UPRISE initiative, aligning with broader government efforts to scale existing nuclear power capacity.

View recap

Lyft, Inc.

LYFT Q2 2026

Reported: 2026-08-10

Lyft’s shares rose 5.9% following Q2 results, driven by top-line acceleration and margin expansion that outpaced expectations, supported by broad-based growth across rideshare, e-bikes, and partnerships.

Key takeaways

Gross bookings increased 23% year-over-year to $5.5 billion, reflecting strong consumer demand.
Adjusted EBITDA expanded 37% year-over-year, benefiting from operational leverage and cost discipline.
The company reported a record 30 million active riders and 262 million rides in the quarter, underscoring sustained marketplace engagement.
Premium ride modes grew double digits for the twelfth consecutive quarter, while the TBR Chauffeuring business hit record performance.
Approximately 30% of North American rideshare rides were linked to strategic partners, highlighting scalable partnership impact.

View recap

MDA Ltd.

MDA.TO Q2 2026

Reported: 2026-08-10

MDA’s shares were little changed following Q2 results as solid revenue growth and an increased full-year guidance were balanced by margins and execution concerns implied implicitly in the muted market response.

Key takeaways

Q2 revenue rose 34% year-over-year to drive adjusted EBITDA of $96 million and a margin of 19.3%.
Full-year guidance midpoint was raised to $1.85 billion in revenue and $350 million in adjusted EBITDA, implying continued double-digit organic growth.
The book-to-bill ratio improved to 1.6x, supported by significant contract expansions including a $474 million increase from Telesat’s Lightspeed constellation.
Large multi-continent government and defense contracts announced, highlighting a diversified and recurring revenue backlog.
Despite strong top-line growth and notable contract wins, the stock’s minimal reaction suggests investor caution around margin sustainability or other operational risks not fully addressed in the call.

View recap

MercadoLibre, Inc.

MELI Q2 2026

Reported: 2026-08-10

Shares fell 3.1% as investors reacted negatively to margin compression driven by incremental cost pressures in Commerce and acquiring, coupled with a cautious outlook on pricing power despite revenue growth.

Key takeaways

Net revenue surpassed $10 billion, growing 50% year-over-year.
EBIT margin declined 550 basis points year-over-year to 6.7%, stable sequentially but pressured by continued strategic investments.
Margin improvement in credit offset by compression primarily in acquiring (Mexico) and Commerce investments, including lowered take rates and promotions in Brazil.
Credit portfolio grew 75% year-over-year to $16.4 billion, maintaining solid asset quality with stable NPLs near historical lows.
Adjusted free cash flow of $214 million after significant capital expenditures and credit book investments totaling $2.1 billion.

View recap

MP Materials Corp.

MP Q2 2026

Reported: 2026-08-10

MP Materials shares rose 6.7% following Q2 as strong volume growth in NdPr sales and advancing commercial magnet initiatives outweighed muted short-term margin pressures and startup costs in the Magnetics segment.

Key takeaways

NdPr sales surged 127% year-over-year, exceeding 1,000 metric tons for the second consecutive quarter, driven by robust customer demand outpacing production growth.
Materials segment revenue including PPA income reached $113.2 million with adjusted EBITDA of $32.5 million, up $45 million year-over-year.
Magnetics segment progressing toward commercial shipments in Q4, delivering magnets to GM for in-vehicle qualification; precursor production margins exceeded 40%.
Consolidated adjusted EBITDA grew $41 million year-over-year to $28.5 million despite slight sequential decline, impacted by planned plant shutdown and Magnetics startup costs.
Entered a substantial multi-year agreement to supply gadolinium oxide to a U.S. aerospace and defense customer, expanding heavy rare earths portfolio strategically.

View recap

The New York Times Company

NYT Q2 2026

Reported: 2026-08-10

Shares fell 14.3% as investors were likely disappointed by cautious forward commentary and signs of margin pressure despite solid subscriber and revenue growth.

Key takeaways

Added 280,000 net new digital subscribers, bringing the total to 13.4 million, with digital-only subscription revenue up 16.4% year-over-year.
Digital advertising revenue grew 21%, boosting total advertising results beyond expectations.
Consolidated revenues increased 11% year-over-year, supported by growth in affiliate, licensing, and other revenue streams.
Adjusted operating profit (AOP) rose 16%, reflecting disciplined cost management amid investments in video and product innovation.
Management acknowledged headwinds from big tech platforms reducing traffic, indicating ongoing challenges to audience growth and potential margin compression.

View recap

Oklo Inc.

OKLO Q2 2026

Reported: 2026-08-10

Oklo’s shares rallied 14.8% following the earnings release, driven primarily by progress in strategic collaborations and government-backed initiatives that enhance its integrated nuclear platform capabilities.

Key takeaways

Participating in the U.S. Department of Energy’s Genesis mission, including a $60 million Phase I award to the INL-led Prometheus project, showcasing expansion in technology development.
Collaboration with NVIDIA and Los Alamos National Laboratory to develop advanced AI models and digital twin technologies aimed at accelerating nuclear fuel validation and deployment.
Engagement with five DOE-selected states for the Nuclear Life Cycle Innovation Campus initiative, positioning Oklo as a key player in future fuel fabrication and reactor development hubs.
Emphasis on Oklo’s vertically integrated model spanning power generation, fuel sourcing/fabrication/recycling, and isotope production to reduce capital intensity and support scalable deployment.
Strategic focus on creating a comprehensive nuclear technology platform rather than isolated business units, aiming to capture value across the full life cycle of nuclear assets.

View recap

Organogenesis Holdings Inc.

ORGO Q2 2026

Reported: 2026-08-10

Shares of Organogenesis Holdings plunged 21.5% following the Q2 2026 earnings release, driven primarily by a significant revenue decline and slower-than-expected recovery in the skin substitute market amid ongoing reimbursement headwinds from recent CMS policy changes.

Key takeaways

Total revenue fell 58% year-over-year, largely due to a 61% plunge in Advanced Wound Care product sales.
Although there was an 18% sequential increase in net product revenue quarter-over-quarter, this improvement was insufficient to offset continued year-over-year pressure.
The 30% increase in wound care unit volumes quarter-over-quarter reflects market share gains but within an overall contracting market.
CMS policy reforms since late 2025 continue to suppress market demand and delay recovery; management acknowledged revenue fell short of previous expectations.
The company is pursuing strategic cost reductions and investing in clinical evidence development while exploring new markets with its ReNu program, though these initiatives have yet to offset near-term headwinds.

View recap

Blue Owl Technology Finance Corp.

OTF Q2 2026

Reported: 2026-08-10

The market responded positively to Blue Owl Technology Finance Corp.'s Q2 results (+12.3%), reflecting investor approval of improved investment economics, capital deployment into higher-yield deals, and a clearer path toward dividend coverage driven by wider spreads and a well-positioned portfolio.

Key takeaways

Adjusted net investment income (NII) per share was $0.30, supporting ongoing earnings growth and a ramp in portfolio earnings.
Net asset value (NAV) per share held steady at $16.48, indicating portfolio stability alongside low industry-leading nonaccrual rates.
New commitments totaled approximately $850 million, with $550 million funded in Q2, reflecting selective deployment amid subdued primary activity.
The portfolio’s net leverage increased by 0.4 turns since last year’s direct listing, now near the low end of the target range, enabling capital deployment into wider spread opportunities.
The company strengthened its capital structure through unsecured bond issuance, extended credit facilities, and secured debt additions, providing liquidity and flexibility for growth.

View recap

Paycom Software, Inc.

PAYC Q2 2026

Reported: 2026-08-10

Paycom delivered a notable beat on growth and client adoption of new products, driving a 23.2% jump in the stock. The market rewarded strong demand for automation, successful major software updates, and ongoing innovation in AI-driven solutions.

Key takeaways

Revenue and profitability projections for 2026 were affirmed or raised, positioning the company to exceed its initial plan.
Newly launched Career and Succession Planning and Asset Management products are seeing early but solid client adoption, expanding Paycom’s addressable market.
Project Arc, the largest system-wide release ever, delivered enhanced customization, scalability, and a reported 4x performance improvement for a large client.
The AI solution IWant continues to accelerate adoption and automate workflows, improving user experience for new employees.
Management emphasized deep leadership bench strength and ongoing innovation as key competitive advantages.

View recap

Petroleo Brasileiro S.A. - Petrobras

PBR Q2 2026

Reported: 2026-08-10

Shares of Petrobras declined 3% following the earnings release, reflecting investor caution amid a cautious outlook and uncertainties around external factors such as Brent oil prices and exchange rates that Petrobras cannot control.

Key takeaways

Oil production surpassed the second quarter target by 200,000 barrels per day, reaching 2.7 million barrels per day and over 3 million barrels per day in equivalent terms.
Refinery utilization exceeded 100%, supporting higher processing volumes without sacrificing diesel and gasoline yields.
Production of byproducts increased 6% compared to the previous quarter, enabling a 40% reduction in diesel imports.
Despite operational milestones, management highlighted dependency on volatile Brent prices and exchange rates, signaling ongoing exposure to external risks.
Capital discipline remains a focus, with investments prioritized on high-return projects under rigorous governance.

View recap

Phillips 66

PSX Q2 2026

Reported: 2026-08-10

Phillips 66 reported a largely steady quarter with mixed segment-level drivers, resulting in a muted market reaction of -0.2%. Despite solid margin gains in several businesses, investors remained cautious due to ongoing uncertainties in the renewables segment and cautious forward commentary.

Key takeaways

Adjusted earnings totaled $3.8 billion, or $9.41 per share, supported by a partial recovery in mark-to-market gains offsetting prior losses.
Midstream benefited from higher margins and volumes, recovering from weather-related disruptions in the prior quarter.
Chemicals saw margin improvements driven by higher polyethylene prices, while Refining captured stronger crack spreads.
Renewable Fuels delivered higher earnings on increased regulatory credit pricing and ramped production, but regulatory uncertainty remains a concern.
The company advanced its debt reduction goals significantly, lowering total debt to $20.6 billion and repaying key term loans ahead of schedule.

View recap

Red Cat Holdings, Inc.

RCAT Q2 2026

Reported: 2026-08-10

Shares rose 6.4% following Red Cat’s Q2 report, reflecting investors’ positive reception to revenue growth, margin improvement, and successful scaling of manufacturing capacity across multiple product lines.

Key takeaways

Quarterly revenue reached $20 million, underpinned by ongoing demand strength across markets.
Gross margin improved to 16%, signaling progress in operational efficiency amidst scaling efforts.
Manufacturing footprint expanded significantly, including a fivefold increase since 2024 to 260,000 square feet, with an additional 12,000 square feet added this quarter.
Launched new platforms such as Hellcat to broaden addressable markets and advanced maritime autonomy with Blue Ops entering mass production of the Variant 7 uncrewed surface vessel.
Continued international sales and government program progress, notably with the Japan Ground Self Defense Force and U.S. Office of Naval Research experiments, validating product competitiveness and market traction.

View recap

The Real Brokerage Inc.

REAX Q2 2026

Reported: 2026-08-10

Shares rallied 23.7% as Real Brokerage delivered revenue and EBITDA growth that materially outpaced the challenging housing market backdrop, reflecting strong unit growth, improving agent productivity, and positive momentum ahead of the RE/MAX transaction.

Key takeaways

Revenue rose 30% year-over-year to $700.6 million, driven by a 27% increase in closed transactions to a record 62,380.
Adjusted EBITDA increased 38% to $27.6 million, reflecting improved core profitability amid difficult market conditions.
Agent count expanded 26% year-over-year to approximately 35,350, with early Q3 numbers exceeding 36,000 agents.
Average agent productivity improved by 1%, and average revenue per transaction increased 2%, indicating operational leverage.
The company reiterated expected cost synergies of approximately $30 million within three years post-close of the pending RE/MAX transaction.

View recap

ResMed Inc.

RMD Q4 2026

Reported: 2026-08-10

Shares dropped 5.4% as investors reacted negatively to a cautious outlook and signs of deceleration in key metrics, despite management’s positive framing of revenue growth and margin expansion.

Key takeaways

Reported 9% headline revenue growth (8% constant currency) for Q4; fiscal 2026 saw 10% total revenue growth.
Gross margins improved due to supply chain efficiencies, contributing to 180 basis points of operating margin expansion for the year.
Non-GAAP EPS grew 16%, supported by operational execution.
Guidance implied a more cautious outlook with emphasis on ongoing operational challenges and transformation work as core markets remain underpenetrated.
Increasing patient demographic shifts and evolving market dynamics signal potential headwinds requiring investments in product and marketing adaptation.

View recap

Sandoz Group AG

SDZ.SW Q2 2026

Reported: 2026-08-10

Sandoz shares rose 7.7% following its H1 earnings as biosimilar sales outpaced expectations, driving robust top-line growth and margin expansion. Confidence in the 2026 guidance and strong commercial execution across key portfolios supported the positive reaction.

Key takeaways

Net sales increased 5% in H1, accelerating to 7% growth in Q2, led by a 20% rise in biosimilars (22% growth in Q2).
Biosimilars now represent 33% of net sales, underpinned by successful launches such as Wyost and Jubbonti capturing market leadership in the U.S. and Europe.
Core EBITDA margin expanded by 90 basis points to 20.9%, reflecting operational leverage despite increased CapEx.
Management free cash flow remained strong at approximately $500 million in the period.
No changes to 2026 guidance were made, signaling confidence in sustained growth amid ongoing regulatory and pipeline progress.

View recap

SharonAI Holdings, Inc. Class A Common Stock

SHAZ Q2 2026

Reported: 2026-08-10

Shares of SharonAI fell 12.7% following earnings as investors reacted negatively to indications of cautious outlook and ongoing supply constraints despite strong contract growth, signaling concerns over execution risks and margin pressures.

Key takeaways

Total secured AI factory capacity increased to 212 megawatts, up 80 megawatts from prior guidance of 132 megawatts.
Contracted capacity grew fourfold with $8.8 billion of total contract value year-to-date, including a $4.9 billion six-year strategic collaboration with NVIDIA.
Significant capital raised: $2.2 billion since December 2025, including a $1.6 billion oversubscribed financing round in June.
Supply-side challenges persist, notably NVIDIA GPU availability constraints and regional power scarcity that could hamper scaling.
Management emphasized the need for continued capital and highly specialized talent, highlighting execution risks despite growth in contracted demand.

View recap

StoneX Group Inc.

SNEX Q3 2026

Reported: 2026-08-10

StoneX shares declined 13.4% post-earnings, driven largely by investor concern over a notable sequential revenue and net income deceleration despite impressive year-over-year growth, suggesting caution about sustainability and margin pressure in a moderating volatility environment.

Key takeaways

Net operating revenues grew 47% year-over-year to $719.7 million but declined 13% sequentially from Q2, indicating a slowdown in momentum.
Net income doubled year-over-year to $127.9 million but fell 27% from the prior quarter, reflecting earnings volatility tied to market conditions.
While Commercial and Institutional segments showed double-digit revenue growth (19% and 56% respectively), the Payment segment posted a more modest 12% increase.
Expenses rose 22% year-over-year due partly to recent acquisitions (R.J. O'Brien and Benchmark), impacting cost structure despite some offset from lower professional fees.
Management highlighted completion of client migrations and FCM consolidation efforts, but the pronounced moderation in volatility suggests challenges ahead for maintaining this growth trajectory.

View recap

Serica Energy plc

SQZ.L Q2 2026

Reported: 2026-08-10

Serica’s shares rose modestly by 2.0% following its half-year results, reflecting steady production growth and improved cash generation, though the market remained cautious likely due to operational seasonality and limited margin expansion.

Key takeaways

Average production increased to just over 45,000 barrels per day, a meaningful improvement driven by higher uptime and new asset contributions, especially the recovery at Triton following maintenance.
Net debt turned into net cash of $26 million from a starting net debt of $200 million, reflecting strong cash flow generation despite $89 million hedging losses.
Operating and lifting costs were elevated by Lancaster’s FPSO lease costs; excluding this, costs stand near $25 per barrel of oil equivalent, indicating a relatively low breakeven for the portfolio.
Revenue more than doubled year-over-year, aided by production growth and a 33% higher realized oil price (pre-hedging) of $93 per barrel.
Production is expected to decline in Q3 due to maintenance on key hubs, with a ramp-up to over 65,000 barrels per day anticipated in Q4 as new assets come online.

View recap

SmartCentres Real Estate Investment Trust

SRU-UN.TO Q2 2026

Reported: 2026-08-10

SmartCentres REIT reported largely in-line Q2 results with stable FFO and continued portfolio occupancy gains, but the modest negative stock reaction (-0.1%) reflects investor caution about a fair value loss on investment properties and rising expenses weighing on adjusted FFO.

Key takeaways

FFO remained flat year-over-year at $0.58 per unit, while adjusted FFO edged down slightly to $0.54 from $0.55, pressured by higher interest and G&A expenses.
Portfolio occupancy improved to 98.1%, with 86% of 2026 lease maturities secured; rental lifts excluding anchors rose 12%.
Cash collection remained strong at 99%, reflecting resilient tenant performance and quality leasing activity.
A significant fair value loss of $196.2 million was recorded, mainly due to the deferral of certain development projects.
Adjusted debt to EBITDA ratio held steady at 9.8x, with liquidity solid at approximately $715 million in cash and undrawn facilities.

View recap

Atlassian Corporation Plc

TEAM Q4 2026

Reported: 2026-08-10

Atlassian’s shares surged 31.5% following a Q4 report that demonstrated accelerating cloud revenue growth and exceptionally strong renewal metrics, signaling investor approval of its expanding enterprise footprint and AI integration despite a cautious full-year ARR growth outlook.

Key takeaways

Total revenue increased 28% year-over-year to $1.8 billion, led by a 31% rise in cloud revenue, which reached $1.2 billion.
Remaining Performance Obligations (RPO) grew 44% year-over-year, reflecting robust deferred revenue and customer commitments.
Net Revenue Retention (NRR) remained above 120%, driven by strong seat expansion and cross-sell within AI-enabled workflows.
Enterprise deals hit record levels at $1 million, $3 million, and $5 million contract thresholds, with customers at $3 million ARR growing 50% and those at $5 million ARR growing 70% year-over-year.
Full-year FY27 ARR guidance was tempered at 18% growth versus FY26’s 23%, reflecting management’s cautious stance on macro uncertainty and the end of a one-point acquisition-driven growth boost.

View recap

Trulieve Cannabis Corp.

TRLV Q2 2026

Reported: 2026-08-10

Shares fell 2.8% as investors appeared cautious about the uncertain impact of the recent business deconsolidation and mixed signals on growth, despite stable revenue and margin performance in the core medical-only operations.

Key takeaways

Reported Q2 revenue of $271 million included combined results until June 3rd, then only the medical-only business after the deconsolidation from Harvest’s mixed-use operations.
The removal of the 280E tax provided a near-term boost to net income and cash flow, but the company did not highlight sustained margin expansion post-deconsolidation.
Management detailed significant near-term growth opportunities in Georgia, Texas (pending license conversion), and customer acquisition from the intoxicating hemp market, but these remain contingent and developmental.
The company completed DEA registration and inspections for its medical dispensaries, a regulatory milestone tied to future federal rescheduling, yet timing of approvals remains pending.
Market reaction suggests investors remain guarded given the complexity of the restructuring and lack of clear forward guidance on mixed-use segment contribution and overall growth trajectory.

View recap

Mammoth Energy Services, Inc.

TUSK Q2 2026

Reported: 2026-08-10

Mammoth Energy’s shares surged 15.3% following a markedly better-than-expected quarter driven by stronger-than-anticipated revenue growth, positive adjusted EBITDA, and multiple upward revisions to full-year guidance. The market rewarded the company’s clear progress on margin expansion and capital deployment discipline.

Key takeaways

Q2 revenue grew 19% sequentially to $26.1 million, more than doubling year-over-year (up 110%).
Adjusted EBITDA rose 37% sequentially to $2.6 million, turning positive for the second consecutive quarter with a 10% margin, ahead of earlier plans.
Rentals segment showed strong lease revenue growth driven by higher utilization in both aviation leasing and equipment rentals, despite a decline in asset sale revenue.
Capital deployment reached $50 million this quarter, including strategic acquisitions expanding fiber optic services and aviation leasing assets with a clear focus on returns.
Full-year 2026 guidance was significantly raised again to over 90% revenue growth and adjusted EBITDA margins exceeding 10%, reflecting the company’s accelerating momentum and sustained cost reductions.

View recap

Unusual Machines, Inc.

UMAC Q2 2026

Reported: 2026-08-10

Shares edged up 1.5% following Unusual Machines' Q2 report, reflecting investor caution despite very strong revenue growth and margin stability as the company continues to invest heavily in scaling.

Key takeaways

Revenue soared 687% year-over-year to $16.7 million, more than doubling sequentially, driven nearly entirely by the Enterprise segment.
Gross margin improved to 34.7%, slightly below 2025 levels but stable amid rapid expansion and operational scaling.
Operating expenses rose to $13.6 million, reflecting increased headcount (from 141 to 240 employees), infrastructure investments, and non-recurring costs totaling $1.8 million.
Adjusted EBITDA loss narrowed substantially from $1.6 million in Q1 to $400,000 in Q2, indicating progress toward profitability but still negative.
Cash and equivalents totaled approximately $315 million, supported by a $60 million capital raise, leaving the company with a strong liquidity position and no debt.

View recap

VTEX

VTEX Q2 2026

Reported: 2026-08-10

VTEX shares declined 5% following a quarter marked by continued revenue deceleration in its core B2C commerce business amid challenging macro conditions. Despite progress in global expansion and new growth initiatives, volume pressure and a cautious outlook on near-term demand weighed on investor sentiment.

Key takeaways

Core subscription revenue from established B2C markets in Brazil and Latin America declined modestly on a constant currency basis, driven by weaker consumer demand and volume contraction rather than retention issues.
Growth initiatives including global expansion, B2B commerce, Ads, and AI-related offerings collectively grew 20% FX-neutral but still comprise a small share of total revenue.
The U.S. and European markets are showing improvements in pipeline quality and enterprise customer wins, supported by partnerships with system integrators and key reference customers.
Management emphasized stable churn rates and competitive win rates but acknowledged longer enterprise sales cycles and headwinds from a promotional environment in Brazil.
Near-term revenue trajectory remains pressured by macroeconomic challenges, despite execution progress toward longer-term AI native transformation and platform differentiation.

View recap

Viatris Inc.

VTRS Q2 2026

Reported: 2026-08-10

Viatris shares fell 6.9% after the quarter as investors reacted negatively to the cautious outlook driven by ongoing manufacturing disruptions and a heightened regulatory burden at its Nashik facility, dampening confidence despite raised guidance.

Key takeaways

Total revenues grew 3.5% year-over-year to $3.8 billion, reflecting moderate operational growth.
Adjusted EBITDA reached $1.2 billion, and adjusted EPS was $0.69 per share, both in line with guidance.
The company raised its 2026 financial guidance midpoint but highlighted intermittent manufacturing disruptions at Nashik following a Q1 fire and FDA inspection in May.
Initiated a comprehensive remediation plan to address FDA observations, adding near-term execution risk.
Commercial execution was solid in Greater China and North America, supported by new product approvals and pipeline progress, though these positives were overshadowed by operational challenges.

View recap

Wheaton Precious Metals Corp.

WPM.TO Q2 2026

Reported: 2026-08-10

Wheaton Precious Metals' shares jumped 6.6% following Q2 results driven by a clear beat on production and the successful close of its landmark Antamina silver streaming transaction, reinforcing confidence in its growth strategy and portfolio expansion.

Key takeaways

Q2 production increased 6% year-over-year to 202,000 gold equivalent ounces, lifted by the expanded Antamina silver stream and contributions from Fenix, Hemlo, Mineral Park, Platreef, and Goose.
Antamina silver production more than doubled to 2.3 million ounces attributable, reflecting the increase in streaming interest from 33.75% to 67.5% as of April 1, 2026.
Despite a decline in gold output at Salobo (-11% YoY) due to lower grades and material sequencing, other assets delivered strong volume improvements.
The company maintains a robust balance sheet with $100 million cash and undrawn capacity on a $2.5 billion credit facility, supporting both current commitments and ongoing accretive acquisitions.
Multiple development projects, including Blackwater expansions and Kurmuk, remain on schedule and budget, underpinning the company’s organic growth profile of 50% by 2030.

View recap

Earnings Recaps

KDDI Corporation

Amplitude Inc. Class A Common Stock

Ardelyx, Inc.

Constellation Energy Corporation

COMPASS Pathways plc

Commerce.com, Inc.

Canadian Natural Resources Limited

Digi International Inc.

Fluence Energy, Inc.

Gevo, Inc.

Groupon, Inc.

IAMGOLD Corporation

Infineon Technologies AG

Lightbridge Corporation

Lyft, Inc.

MDA Ltd.

MercadoLibre, Inc.

MP Materials Corp.

The New York Times Company

Oklo Inc.

Organogenesis Holdings Inc.

Blue Owl Technology Finance Corp.

Paycom Software, Inc.

Petroleo Brasileiro S.A. - Petrobras

Phillips 66

Red Cat Holdings, Inc.

The Real Brokerage Inc.

ResMed Inc.

Sandoz Group AG

SharonAI Holdings, Inc. Class A Common Stock

StoneX Group Inc.

Serica Energy plc

SmartCentres Real Estate Investment Trust

Atlassian Corporation Plc

Trulieve Cannabis Corp.

Mammoth Energy Services, Inc.

Unusual Machines, Inc.

VTEX

Viatris Inc.

Wheaton Precious Metals Corp.

Community

Trending This Week

Notifications